wegovy weight loss news - Search News

Novo Nordisk, Wegovy

Barron's on MSN · 11h

Novo’s Wegovy Gets Backing of a Regulator for Heart Condition Treatment. FDA Could Be Next.

Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions. Approval in the U.S.–Novo’s biggest market for obesity drugs–by the Food and Drug Administration could be next.

Wall Street Journal · 18h

Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity-Related Heart Failure

Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure in obese patients.

Benzinga.com · 12h

European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart failure symptoms, physical limitations, and exercise function in patients with obesity-related HFpEF.

Business Insider · 21h

Novo Nordisk's Wegovy Recommended For Label Update To Reflect Heart Failure Benefits

Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a

Winding, fitful path to weight loss drug Ozempic

Cost of weight-loss drugs has many exploring sources beyond doctors

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to set them up with Wegovy, Zepbound and other weight-loss drugs.

New York Post on MSN · 7d

Which Ozempic-like drugs cause the most weight loss? The answer may surprise you

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in recent years.

The American Journal of Manage… · 5h

5 Things Americans Should Know About Weight Loss Drugs

Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, and their potential downsides is key to making informed decisions.

9h

Novo Nordisk's experimental weight loss pill has some concerning side effects

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...

1don MSN

Maker of Ozempic, Wegovy sues Minnesota clinic over knockoff weight-loss medication

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

16h

China Cracks Down on Illegal Copies of Novo’s Weight-Loss Drug

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...

ConsumerAffairs1d

The battle of the weight loss injectables has a clear winner

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

2d

Hims & Hers to Offer Weight Loss Medication for Workers in Specific Professions

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

2d

Is Wegovy covered by Medicare?

Medicare may cover Wegovy for adults with cardiovascular disease and either obesity or overweight. Learn more about Medicare ...

9h

Novo Nordisk shares drop nearly 5% on disappointing obesity pill data

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results